Status:

NOT_YET_RECRUITING

The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction

Lead Sponsor:

West China Hospital

Conditions:

STEMI

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The primary objective of the PERI-STEMI trial is to assess whether sacubitril-valsartan is more effective in preventing adverse LV remodeling for patients with ST-elevation myocardial infarction (STEM...

Eligibility Criteria

Inclusion

  • Aged between 18 - 75 years old
  • First-time ST-segment elevation myocardial infarction based on the newest ESC guidelines
  • Timely primary percutaneous coronary intervention within 12 hours from onset
  • Written informed consent acquired

Exclusion

  • Known history of or persistent clinical chronic heart failure prior to randomization
  • Previous use of ARNI, or intolerance or contraindications to study drugs including ARNI or ACEI
  • History of significant chronic coronary obstruction and adverse ventricular remodeling
  • History of any cardiomyopathy, valvular heart disease, congenital heart disease, stent or CABG, or planned open-heart surgery within 3 months
  • History of hepatic impairment or history of cirrhosis with evidence of portal hypertension
  • History of chronic renal dysfunction, or eGFR \< 30 ml/min/1.73 m2
  • History of malignancy and with a life span less than one year
  • Patients with a known history of angioedema related to previous ACEIs/ARB therapy.
  • With contraindication to MRI examination (pacemaker and claustrophobia) or cannot finish breath-holding when lying on the examination bed
  • Pregnancy or nursing women

Key Trial Info

Start Date :

November 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

376 Patients enrolled

Trial Details

Trial ID

NCT04912167

Start Date

November 1 2021

End Date

June 1 2026

Last Update

September 29 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

West China Hospital

Chengdu, Sichuan, China, 621000